赵廷丽,刘 阳,李征征,王 来,孙 立,袁胜涛.抗凋亡蛋白Mcl-1及其抑制剂的研究进展[J].,2019,19(6):1184-1187 |
抗凋亡蛋白Mcl-1及其抑制剂的研究进展 |
Research Progress of Anti-apoptotic Protein Mcl-1 and its Inhibitors |
投稿时间:2018-04-30 修订日期:2018-05-26 |
DOI:10.13241/j.cnki.pmb.2019.06.041 |
中文关键词: Mcl-1蛋白 Bcl-2蛋白 抗凋亡 抑制剂 |
英文关键词: Mcl-1 protein Bcl-2 protein Anti apoptosis Inhibitor |
基金项目:国家自然科学基金项目(81773766) |
|
摘要点击次数: 753 |
全文下载次数: 946 |
中文摘要: |
摘要:骨髓细胞白血病蛋白Mcl-1是Bcl-2家族蛋白中重要的抗凋亡蛋白成员,其在多种恶性肿瘤(急性细胞性白血病、多发性骨髓瘤等)中都具有高表达的特点,导致肿瘤细胞对传统化疗药物及Bcl-2抑制剂产生耐药性。Mcl-1作为抗肿瘤药物研发的重要靶点正日益受到相关研究人员的关注,其中Mcl-1新型抑制剂以及联合抑制剂的研究取得了较大进展。本文将对Mcl-1蛋白结构和功能以及相关抑制剂的研究做更深入的分析和总结。 |
英文摘要: |
ABSTRACT: Bone marrow cell leukemia protein Mcl-1 is an important member of the anti-apoptotic protein in the Bcl-2 family protein, and has high expression in many kinds of malignant tumor (acute cell leukemia, multiple myeloma, etc), resulting in drug resistance to traditional chemotherapeutic agents and Bcl-2 inhibitors. As an important target for the research and development of antitumor drugs, Mcl-1 is increasingly concerned by the researchers. Great progress has been made in the research of new Mcl-1 inhibitors and joint inhibitors. This article will make a more in-depth analysis of the structure and function of Mcl-1 protein and related inhibitors, and results of the study will be of great significance for the treatment of cancer. |
查看全文
查看/发表评论 下载PDF阅读器 |
关闭 |